PregFit Adventure: Strengthening Mothers-to-Be (PregFit)

Launched by UNIVERSITY OF JAÉN · Jun 18, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring whether a special exercise program using a video game can help improve the strength and fitness of pregnant women who have low-risk pregnancies. The program involves using a Nintendo Switch game that encourages gentle physical activity like jogging, squatting, and stretching, designed specifically to be safe and supportive during pregnancy. The goal is to see if this fun, game-based exercise can help expectant mothers stay active and feel stronger throughout their pregnancy.

Women who are eligible to join the study must be over 18, have a low-risk pregnancy, be able to understand and communicate in Spanish, and be physically able to exercise for about 30 minutes, two to three times a week, for at least eight weeks. Participants will be randomly assigned to either the group using the exercise game or a control group that receives the usual pregnancy care and education. Those in the exercise group will use the game with guidance from a health professional, and the program includes helpful features like knee support to make movements easier and safer. The study will take place at health centers in Andalusia, Spain, and aims to learn whether this fun, interactive exercise can be a helpful part of pregnancy care.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women at low obstetric risk and with no musculoskeletal or health problems affecting their physical condition, ability to exercise or participate in the exergame activities.
• • Read the information sheet and sign the informed consent form to agree to take part in the study.
• • \>18 years of age
• • Spanish comprehension and communication skills
• • Able to perform physical activity related to the use of the device for at least 30 minutes, 2-3 times a week, for at least 8 weeks
• Exclusion Criteria:
• • Failure to meet any of the inclusion criteria
• • Giving birth during the procedure and at least 8 weeks of device use have not elapsed.